Litcius/Paper detail

Tumor Accumulation and Off-Target Biodistribution of an Indocyanine-Green Fluorescent Nanotracer: An Ex Vivo Study on an Orthotopic Murine Model of Breast Cancer

Marta Sevieri, Leopoldo Sitia, Arianna Bonizzi, Marta Truffi, Serena Mazzucchelli, Fabio Corsi

2021International Journal of Molecular Sciences20 citationsDOIOpen Access PDF

Abstract

Indocyanine green (ICG) is a near infrared fluorescent tracer used in image-guided surgery to assist surgeons during resection. Despite appearing as a very promising tool for surgical oncology, its employment in this area is limited to lymph node mapping or to laparoscopic surgery, as it lacks tumor targeting specificity. Recently, a nanoformulation of this dye has been proposed with the aim toward tumor targeting specificity in order to expand its employment in surgical oncology. This nanosystem is constituted by 24 monomers of H-Ferritin (HFn), which self-assemble into a spherical cage structure enclosing the indocyanine green fluorescent tracer. These HFn nanocages were demonstrated to display tumor homing due to the specific interaction between the HFn nanocage and transferrin receptor 1, which is overexpressed in most tumor tissues. Here, we provide an ex vivo detailed comparison between the biodistribution of this nanotracer and free ICG, combining the results obtained with the Karl Storz endoscope that is currently used in clinical practice and the quantification of the ICG signal derived from the fluorescence imaging system IVIS Lumina II. These insights demonstrate the suitability of this novel HFn-based nanosystem in fluorescence-guided oncological surgery.

Topics & Concepts

Indocyanine greenBiodistributionEx vivoMedicineLymph nodeFluorescence-lifetime imaging microscopySentinel lymph nodeBreast cancerImage-guided surgeryIn vivoPathologyCancer researchFluorescenceBiomedical engineeringChemistryCancerRadiologyInternal medicineBiologyPhysicsQuantum mechanicsBiotechnologyNanoparticle-Based Drug DeliveryAdvanced biosensing and bioanalysis techniquesNanoplatforms for cancer theranostics